The human EKC/KEOPS complex is recruited to cullin2 ubiquitin ligases by the human tumour antigen PRAME

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Costessi, Adalberto ^a   Mahrour, Nawel ^b   Sharma, Vikram ^a   Stunnenberg, Rieka ^a   Stoel, Marieke A ^a   Tijchon, Esther ^a   Conaway, Joan W ^b,c   Conaway, Ronald C ^b,c   Stunnenberg, Hendrik G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EKC COMPLEX; KEOPS COMPLEX; L ANTIGEN FAMILY MEMBER 3 PROTEIN; MULTIPROTEIN COMPLEX; O SIALOGLYCOPROTEIN ENDOPEPTIDASE; PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA; PROTEINASE; TUMOR ANTIGEN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION;

ANTIGENS, NEOPLASM; CULLIN PROTEINS; HELA CELLS; HUMANS; K562 CELLS; PROTEIN BINDING; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84865058918     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042822     Document Type: Article

References (35)

1. Ikeda H, Lethé B, Lehmann F, van Baren N, Baurain JF, et al. (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6: 199-208.
2. Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, et al. (2008) Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 9: R139 doi:10.1186/gb-2008-9-9-r139.
3. Allander SV, Illei PB, Chen Y, Antonescu CR, Bittner M, et al. (2002) Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 161: 1587-1595.
4. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, et al. (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102: 6092-6097 doi:10.1073/pnas.0501564102.
5. Oberthuer A, Hero B, Spitz R, Berthold F (2004) The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome. Clinical Cancer Research.
6. Partheen K, Levan K, Osterberg L, Claesson I, Fallenius G, et al. (2008) Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. Int J Cancer 123: 2130-2137 doi:10.1002/ijc.23758.
7. Radich JP, Dai H, Mao M, Oehler V, Schelter J, et al. (2006) Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA 103: 2794-2799 doi:10.1073/pnas.0510423103.
8. Doolan P, Clynes M, Kennedy S, Mehta JP, Crown J, et al. (2008) Prevalence and prognostic and predictive relevance of PRAME in breast cancer. Breast Cancer Res Treat 109: 359-365 doi:10.1007/s10549-007-9643-3.
9. Epping MT, Hart AAM, Glas AM, Krijgsman O, Bernards R, (2008) PRAME expression and clinical outcome of breast cancer. Br J Cancer 99: 398-403 doi:10.1038/sj.bjc.6604494.
10. Santamaría C, Chillón MC, García-Sanz R, Balanzategui A, Sarasquete ME, et al. (2008) The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia. Haematologica 93: 1797-1805 doi:10.3324/haematol.13214.
11. Epping MT, Wang L, Edel MJ, Carlée L, Hernandez M, et al. (2005) The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122: 835-847 doi:10.1016/j.cell.2005.07.003.
12. Steinbach D, Pfaffendorf N, Wittig S, Gruhn B, (2007) PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia. Cancer Genet Cytogenet 177: 51-54 doi:10.1016/j.cancergencyto.2007.05.011.
13. Tajeddine N, Gala J-L, Louis M, Van Schoor M, Tombal B, et al. (2005) Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo. Cancer Res 65: 7348-7355 doi:10.1158/0008-5472.CAN-04-4011.
14. Tanaka N, Wang Y-H, Shiseki M, Takanashi M, Motoji T, (2011) Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells. Leuk Res 35: 1219-1225 doi:10.1016/j.leukres.2011.04.005.
15. Costessi A, Mahrour N, Tijchon E, Stunnenberg R, Stoel MA, et al. (2011) The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters. EMBO J 30: 3786-3798 doi:10.1038/emboj.2011.262.
16. Downey M, Houlsworth R, Maringele L, Rollie A, Brehme M, et al. (2006) A genome-wide screen identifies the evolutionarily conserved KEOPS complex as a telomere regulator. Cell 124: 1155-1168 doi:10.1016/j.cell.2005.12.044.
17. Kisseleva-Romanova E, Lopreiato R, Baudin-Baillieu A, Rousselle J-C, Ilan L, et al. (2006) Yeast homolog of a cancer-testis antigen defines a new transcription complex. EMBO J 25: 3576-3585 doi:10.1038/sj.emboj.7601235.
18. Reinders J, Zahedi RP, Pfanner N, Meisinger C, Sickmann A, (2006) Toward the complete yeast mitochondrial proteome: multidimensional separation techniques for mitochondrial proteomics. J Proteome Res 5: 1543-1554 doi:10.1021/pr050477f.
19. Galperin MY, (2008) Social bacteria and asocial eukaryotes. Environ Microbiol 10: 281-288 doi:10.1111/j.1462-2920.2007.01552.x.
20. Daugeron M-C, Lenstra TL, Frizzarin M, Yacoubi El B, Liu X, et al. (2011) Gcn4 misregulation reveals a direct role for the evolutionary conserved EKC/KEOPS in the t6A modification of tRNAs. Nucleic Acids Res 39: 6148-6160 doi:10.1093/nar/gkr178.
21. Yacoubi El B, Hatin I, Deutsch C, Kahveci T, Rousset J-P, et al. (2011) A role for the universal Kae1/Qri7/YgjD (COG0533) family in tRNA modification. EMBO J 30: 882-893 doi:10.1038/emboj.2010.363.
22. Srinivasan M, Mehta P, Yu Y, Prugar E, Koonin EV, et al. (2011) The highly conserved KEOPS/EKC complex is essential for a universal tRNA modification, t6A. EMBO J 30: 873-881 doi:10.1038/emboj.2010.343.
23. Yarian C, Townsend H, Czestkowski W, Sochacka E, Malkiewicz AJ, et al. (2002) Accurate translation of the genetic code depends on tRNA modified nucleosides. J Biol Chem 277: 16391-16395 doi:10.1074/jbc.M200253200.
24. Alpen B, Güre AO, Scanlan MJ, Old LJ, Chen Y-T, (2002) A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved. Gene 297: 141-149.
25. Xu Z, Page RC, Gomes MM, Kohli E, Nix JC, et al. (2008) Structural basis of nucleotide exchange and client binding by the Hsp70 cochaperone Bag2. Nat Struct Mol Biol 15: 1309-1317 doi:10.1038/nsmb.1518.
26. Wang Q, Liu Y, Soetandyo N, Baek K, Hegde R, et al. (2011) A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation. Mol Cell 42: 758-770 doi:10.1016/j.molcel.2011.05.010.
27. Mariappan M, Li X, Stefanovic S, Sharma A, Mateja A, et al. (2010) A ribosome-associating factor chaperones tail-anchored membrane proteins. Nature 466: 1120-1124 doi:10.1038/nature09296.
28. Mao DYL, Neculai D, Downey M, Orlicky S, Haffani YZ, et al. (2008) Atomic structure of the KEOPS complex: an ancient protein kinase-containing molecular machine. Mol Cell 32: 259-275 doi:10.1016/j.molcel.2008.10.002.
29. Hecker A, Lopreiato R, Graille M, Collinet B, Forterre P, et al. (2008) Structure of the archaeal Kae1/Bud32 fusion protein MJ1130: a model for the eukaryotic EKC/KEOPS subcomplex. EMBO J. doi:10.1038/emboj.2008.157.
30. Ikeda S, Ayabe H, Mori K, Seki Y, Seki S, (2002) Identification of the functional elements in the bidirectional promoter of the mouse O-sialoglycoprotein endopeptidase and APEX nuclease genes. Biochemical and Biophysical Research Communications 296: 785-791.
31. Abe Y, Matsumoto S, Wei S, Nezu K, Miyoshi A, et al. (2001) Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes. J Biol Chem 276: 44003-44011 doi:10.1074/jbc.M105669200.
32. Facchin S, Ruzzene M, Peggion C, Sartori G, Carignani G, et al. (2007) Phosphorylation and activation of the atypical kinase p53-related protein kinase (PRPK) by Akt/PKB. Cell Mol Life Sci 64: 2680-2689 doi:10.1007/s00018-007-7179-7.
33. Facchin S, Lopreiato R, Ruzzene M, Marin O, Sartori G, et al. (2003) Functional homology between yeast piD261/Bud32 and human PRPK: both phosphorylate p53 and PRPK partially complements piD261/Bud32 deficiency. FEBS Lett 549: 63-66.
34. Miyoshi A, Kito K, Aramoto T, Abe Y, Kobayashi N, et al. (2003) Identification of CGI-121, a novel PRPK (p53-related protein kinase)-binding protein. Biochemical and Biophysical Research Communications 303: 399-405.
35. Mahrour N, Redwine WB, Florens L, Swanson SK, Martin-Brown S, et al. (2008) Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem 283: 8005-8013 doi:10.1074/jbc.M706987200.